The subject of the order is successive delivery of medicines for a period of 12 months
Polatuzumab vedotinA detailed description of the subject of the contract is included in the offer form
GuselkumabA detailed description of the subject of the contract is included in the offer form
Human normal immunoglobulinA detailed description of the subject of the contract is included in the offer form
Human normal immunoglobulinA detailed description of the subject of the contract is included in the offer form
PaclitaxelumA detailed description of the subject of the contract is included in the offer form
FARICIMABA detailed description of the subject of the contract is included in the offer form
Ryboflawina do Cross-linkinguA detailed description of the subject of the contract is included in the offer form
CemiplimabA detailed description of the subject of the contract is included in the offer form
LenalidomideA detailed description of the subject of the contract is included in the offer form
BevacizumabA detailed description of the subject of the contract is included in the offer form
BlinatumomabA detailed description of the subject of the contract is included in the offer form
ozanimodA detailed description of the subject of the contract is included in the offer form
LuspaterceptA detailed description of the subject of the contract is included in the offer form
Brentuximab vedotinA detailed description of the subject of the contract is included in the offer form
IVACAFTOR + TEZACAFTOR, CYTARABINE + DAUNORUBICINA detailed description of the subject of the contract is included in the offer form